Moderate Probable

Description

Doxycycline may enhance warfarin's anticoagulant effect, particularly in patients whose vitamin K intake is already limited.

Mechanism

Doxycycline reduces intestinal flora that produce vitamin K2, potentially decreasing cofactor availability for synthesis of clotting factors II, VII, IX, and X.

Clinical Significance

INR elevations are typically modest but can be clinically relevant in elderly patients or those with dietary vitamin K insufficiency.

Management

Monitor INR after starting doxycycline; counsel patients on consistent dietary vitamin K intake during antibiotic therapy.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.